Azza M. Kamel

1.1k total citations
42 papers, 789 citations indexed

About

Azza M. Kamel is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Azza M. Kamel has authored 42 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 11 papers in Immunology. Recurrent topics in Azza M. Kamel's work include Acute Lymphoblastic Leukemia research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Immune Cell Function and Interaction (7 papers). Azza M. Kamel is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Immune Cell Function and Interaction (7 papers). Azza M. Kamel collaborates with scholars based in Egypt, United States and India. Azza M. Kamel's co-authors include Jacques Bertoglio, Yann F. Mahé, Hiro Wakasugi, Thomas Tursz, D Fradelizi, L Rimsky, Amal Fawzy, Alaa Elhaddad, F E Alexander and Mel Greaves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Radiotherapy and Oncology.

In The Last Decade

Azza M. Kamel

40 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azza M. Kamel Egypt 13 277 268 206 180 175 42 789
Brigitte Lescoeur France 13 319 1.2× 217 0.8× 135 0.7× 141 0.8× 214 1.2× 28 711
Hiroyuki Takahashi Japan 18 369 1.3× 383 1.4× 357 1.7× 244 1.4× 167 1.0× 58 1.1k
O B Eden United Kingdom 5 459 1.7× 254 0.9× 280 1.4× 163 0.9× 241 1.4× 7 771
J. Wiemels United Kingdom 4 462 1.7× 260 1.0× 222 1.1× 120 0.7× 251 1.4× 4 705
Mette Østergaard Denmark 14 241 0.9× 416 1.6× 384 1.9× 163 0.9× 49 0.3× 29 843
Irina Costea Canada 17 471 1.7× 159 0.6× 336 1.6× 137 0.8× 299 1.7× 23 1.1k
Claire Oudin France 21 152 0.5× 550 2.1× 277 1.3× 193 1.1× 165 0.9× 39 1.1k
D. Stirling United Kingdom 14 153 0.6× 143 0.5× 206 1.0× 103 0.6× 58 0.3× 26 889
Michał Matysiak Poland 15 129 0.5× 282 1.1× 444 2.2× 134 0.7× 106 0.6× 117 937
Jana Březinová Czechia 20 280 1.0× 486 1.8× 300 1.5× 95 0.5× 58 0.3× 94 1.1k

Countries citing papers authored by Azza M. Kamel

Since Specialization
Citations

This map shows the geographic impact of Azza M. Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azza M. Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azza M. Kamel more than expected).

Fields of papers citing papers by Azza M. Kamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azza M. Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azza M. Kamel. The network helps show where Azza M. Kamel may publish in the future.

Co-authorship network of co-authors of Azza M. Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Azza M. Kamel. A scholar is included among the top collaborators of Azza M. Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azza M. Kamel. Azza M. Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kamel, Azza M., et al.. (2023). Variability of contribution of 1,25 (OH)2D3 (vitamin D) level to hematopoietic stem cell transplantation outcome. Clinical Nutrition ESPEN. 58. 355–361.
4.
Samra, Mohamed, et al.. (2020). Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 20(6). 383–393. 12 indexed citations
5.
Kamel, Azza M., et al.. (2019). IL12 and IFNγ secretion by donor mononuclear cells in response to host antigens may predict acute GVHD after HSCT. Immunobiology. 224(5). 659–665. 5 indexed citations
6.
Kamel, Azza M., et al.. (2018). The impact of cytokine gene polymorphisms on the outcome of HLA matched sibling hematopoietic stem cell transplantation. Cytokine. 110. 404–411. 6 indexed citations
7.
Elhaddad, Alaa, et al.. (2017). The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling. Human Immunology. 78(11-12). 684–691. 3 indexed citations
8.
Kamel, Azza M., et al.. (2016). Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters. Journal of the Egyptian National Cancer Institute. 28(1). 31–37. 9 indexed citations
9.
Kamel, Azza M., et al.. (2015). Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer. Tumor Biology. 37(6). 7565–7572. 48 indexed citations
10.
Kamel, Azza M., et al.. (2015). N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. Tumor Biology. 36(8). 6341–6348. 18 indexed citations
11.
Samra, Mohamed, et al.. (2013). The prognostic significance of minimal residual disease in adult Egyptian patients with precursor acute lymphoblastic leukemia. Journal of the Egyptian National Cancer Institute. 25(3). 135–142. 7 indexed citations
12.
Kamel, Azza M., et al.. (2009). Prognostic Utility of Routine Chimerism Testing at 2 to 6 Months after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(3). 352–359. 28 indexed citations
13.
Kamel, Azza M., et al.. (2005). Prevalence of anti human herpes virus-6 IgG and its receptor in acute leukemia (membrane cofactor protein: MCP, CD46).. PubMed. 17(1). 29–34. 4 indexed citations
14.
Zekri, Abdel‐Rahman N., et al.. (2005). HLA alleles in Egyptian HCV genotype-4 carriers.. PubMed. 12(1). 77–86. 11 indexed citations
15.
Sidhom, Iman, et al.. (2004). Outcome and Prognostic Factors of Acute Lymphoblastic Leukemia in Children at the National Cancer Institute, Egypt. Journal of Pediatric Hematology/Oncology. 26(8). 507–514. 26 indexed citations
17.
Kamel, Azza M., et al.. (1999). Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 24(4). 355–358. 61 indexed citations
18.
Bhatia, Karishma, G Spangler, S H Advani, et al.. (1993). MOLECULAR CHARACTERIZATION OF SCL REARRANGEMENTS IN T-CELL ALL FROM INDIA AND EGYPT. International Journal of Oncology. 2(5). 725–30. 5 indexed citations
19.
Kamel, Azza M., et al.. (1990). Phenotypic analysis of T-cell acute lymphoblastic leukemia in Egypt. Leukemia Research. 14(7). 601–609. 6 indexed citations
20.
Kamel, Azza M., et al.. (1989). Immunological phenotypic pattern of acute lymphoblastic leukaemia in Egypt. Leukemia Research. 13(7). 519–525. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026